Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 29;4(2):467-471.
doi: 10.1021/acsptsci.0c00173. eCollection 2021 Apr 9.

Discriminative Stimulus Effects of Substituted Tryptamines in Rats

Affiliations

Discriminative Stimulus Effects of Substituted Tryptamines in Rats

Michael B Gatch et al. ACS Pharmacol Transl Sci. .

Abstract

Novel synthetic compounds have been available for decades as quasi-legal alternatives to controlled substances. The hallucinogen-like effects of eight novel substituted tryptamines were evaluated to determine their potential abuse liability. Male Sprague-Dawley rats were trained to discriminate 2,5-dimethoxy-4-methylamphetamine (DOM, 0.5 mg/kg, i.p., 30 min) from saline. 4-Acetoxy-N,N-diethyltryptamine (4-AcO-DET), 4-hydroxy-N-methyl-N-ethyltryptamine (4-OH-MET), 4-hydroxy-N,N-diethyltryptamine (4-OH-DET), 4-acetoxy-N-methyl-N-isopropyltryptamine (4-AcO-MiPT), 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT), 4-hydroxy-N,N-dimethyltryptamine (4-OH-DMT, psilocin), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 4-acetoxy-N,N-diisopropyltryptamine (4-AcO-DiPT), and 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT) were tested for their ability to substitute for the discriminative stimulus effects of DOM. All test compounds fully substituted for DOM with potencies less than or equal to that of DOM. 4-OH-MET, 4-OH-DET, 4-OH-DMT, and 4-AcO-DMT decreased response rate at doses that fully substituted. Because the test compounds produced DOM-like discriminative stimulus effects, they may have similar abuse liability as DOM. 4-Acetoxy substituted compounds were less potent than 4-hydroxy substituted compounds, and the N,N-diisopropyl compounds were less potent than the dimethyl, diethyl, N-methyl-N-ethyl, and N-methyl-N-isopropyl compounds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Chemical structures of the test compounds. Tryptamine and its potential structural substitutions are shown on the left; DOM is shown on the right.
Figure 2
Figure 2
Substitution for the discriminative stimulus effects of DOM. Top panels show percentage of total responses made on the drug-appropriate lever. Bottom panels show rate of responding in responses per second (r/s). 4-AcO-DET (n = 9), 4-OH-MET (n = 9), 4-OH-DET (n = 8), 4-AcO-MiPT (n = 9), 5-MeO-MiPT (n = 6), 4-AcO-DMT (n = 9), 4-AcO-DiPT (n = 8), and 4-OH-DiPT (n = 6) unless otherwise shown. Ctrl indicates vehicle and training drug control values. * indicates response rate different from vehicle control (p < 0.05). Error bars show standard error of the mean.

References

    1. Guzmán G. (2008) Hallucinogenic mushrooms in Mexico: An overview. Econ. Bot. 62, 404–412. 10.1007/s12231-008-9033-8. - DOI
    1. Griffiths R. R.; Johnson M. W.; Carducci M. A.; Umbricht A.; Richards W. A.; Richards B. D.; Cosimano M. P.; Klinedinst M. A. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J. Psychopharmacol. 30, 1181–1197. 10.1177/0269881116675513. - DOI - PMC - PubMed
    2. Shulgin A., and Shulgin A. (1997) TIHKAL: The Continuation. Transform Press, Berkeley, CA.
    1. Whelan A.; Johnson M. I. (2018) Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?. Pain Manag 8, 217–229. 10.2217/pmt-2017-0068. - DOI - PubMed
    1. Bogenschutz M. P.; Johnson M. W. (2016) Classic hallucinogens in the treatment of addictions. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 64, 250–8. 10.1016/j.pnpbp.2015.03.002. - DOI - PubMed
    1. Carbonaro T. M.; Johnson M. W.; Griffiths R. R. (2020) Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology (Berl) 237 (8), 2293–2304. 10.1007/s00213-020-05533-9. - DOI - PMC - PubMed

LinkOut - more resources